HuGE Literature Finder
Records
1
-
30
| Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia. Bone marrow transplantation 2022 Sep . Song Ga-Young, Kim TaeHyung, Ahn Seo-Yeon, Jung Sung-Hoon, Kim Mihee, Yang Deok-Hwan, Lee Je-Jung, Choi Seung Hyun, Kim Mi Yeon, Jung Chul Won, Jang Jun-Ho, Kim Hee Je, Moon Joon Ho, Sohn Sang Kyun, Won Jong-Ho, Park Seong-Kyu, Kim Sung-Hyun, Zhang Zhaolei, Ahn Jae-Sook, Kim Hyeoung-Joon, Kim Dennis Dong Hw |
| The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China. Frontiers in oncology 2022 12 846573. Xiao Jinyan, Cai Zihong, Wang Hao, Li Xuekai, Zhou Biqi, Liu Yujie, Wang Ying, Xu Peipei, Wang Li, Wu Depei, Dou Liping, Zhou Hongsheng, Xu Ya |
| The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Cancers 2021 May 13 (10): . Ayala Rosa, Rapado Inmaculada, Onecha Esther, Martínez-Cuadrón David, Carreño-Tarragona Gonzalo, Bergua Juan Miguel, Vives Susana, Algarra Jesus Lorenzo, Tormo Mar, Martinez Pilar, Serrano Josefina, Herrera Pilar, Ramos Fernando, Salamero Olga, Lavilla Esperanza, Gil Cristina, López Lorenzo Jose Luis, Vidriales María Belén, Labrador Jorge, Falantes José Francisco, Sayas María José, Paiva Bruno, Barragán Eva, Prosper Felipe, Sanz Miguel Ángel, Martínez-López Joaquín, Montesinos Pau, On Behalf Of The Programa Para El Estudio de la Terapeutica En Hemopatias Malignas Pethema Cooperative Study Grou |
| Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients. Clinical epigenetics 2021 Apr 13 (1): 77. Stomper Julia, Meier Ruth, Ma Tobias, Pfeifer Dietmar, Ihorst Gabriele, Blagitko-Dorfs Nadja, Greve Gabriele, Zimmer Dennis, Platzbecker Uwe, Hagemeijer Anne, Schmitt-Graeff Ingrid, Lübbert Micha |
| Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 2021 (7): 781-789. Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal |
| Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood advances 2021 Mar 5 (5): 1442-1451. Luque Paz Damien, Riou Jérémie, Verger Emmanuelle, Cassinat Bruno, Chauveau Aurélie, Ianotto Jean-Christophe, Dupriez Brigitte, Boyer Françoise, Renard Maxime, Mansier Olivier, Murati Anne, Rey Jérôme, Etienne Gabriel, Mansat-De Mas Véronique, Tavitian Suzanne, Nibourel Olivier, Girault Stéphane, Le Bris Yannick, Girodon François, Ranta Dana, Chomel Jean-Claude, Cony-Makhoul Pascale, Sujobert Pierre, Robles Margot, Ben Abdelali Raouf, Kosmider Olivier, Cottin Laurane, Roy Lydia, Sloma Ivan, Vacheret Fabienne, Wemeau Mathieu, Mossuz Pascal, Slama Borhane, Cussac Vincent, Denis Guillaume, Walter-Petrich Anouk, Burroni Barbara, Jézéquel Nathalie, Giraudier Stéphane, Lippert Eric, Socié Gérard, Kiladjian Jean-Jacques, Ugo Valér |
| Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia. Scientific reports 2021 Jan 11 (1): 769. Chang Ya-Hsuan, Yu Chih-Hsiang, Jou Shiann-Tarng, Lin Chien-Yu, Lin Kai-Hsin, Lu Meng-Yao, Wu Kang-Hsi, Chang Hsiu-Hao, Lin Dong-Tsamn, Lin Shu-Wha, Chen Hsuan-Yu, Yang Yung- |
| [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 2004-2010. Cen Yan-Xia, Li Y |
| Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis. Medicine 2020 Aug 99 (34): e21900. Huang Xinyue, Wang Xiaox |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| Defining Acute Myeloid Leukemia Ontogeny in Older Patients. Clinical lymphoma, myeloma & leukemia 2019 Nov . Melody Megan, Kuykendall Andrew, Sallman David, Al Ali Najla, Zhang Ling, Talati Chetasi, Padron Eric, Sweet Kendra, Extermann Martine, List Alan, Lancet Jeffrey, Komrokji Ra |
| Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis. Clinical lymphoma, myeloma & leukemia 2018 Jun . Lee Yen-Chien, Hsieh Chung-Cheng, Lee Yen-Ling, Li Chung- |
| Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1. Blood cancer journal 2018 Jan 8 (1): 4. Saygin Caner, Hirsch Cassandra, Przychodzen Bartlomiej, Sekeres Mikkael A, Hamilton Betty K, Kalaycio Matt, Carraway Hetty E, Gerds Aaron T, Mukherjee Sudipto, Nazha Aziz, Sobecks Ronald, Goebel Christopher, Abounader Donna, Maciejewski Jaroslaw P, Advani Anjali |
| Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation. Annals of hematology 2017 Jun . Heuser Michael, Gabdoulline Razif, Löffeld Patrick, Dobbernack Vera, Kreimeyer Henriette, Pankratz Mira, Flintrop Madita, Liebich Alessandro, Klesse Sabrina, Panagiota Victoria, Stadler Michael, Wichmann Martin, Shahswar Rabia, Platzbecker Uwe, Thiede Christian, Schroeder Thomas, Kobbe Guido, Geffers Robert, Schlegelberger Brigitte, Göhring Gudrun, Kreipe Hans-Heinrich, Germing Ulrich, Ganser Arnold, Kröger Nicolaus, Koenecke Christian, Thol Felicit |
| Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis. Leukemia 2017 06 31 (6): 1286-1295. Thol F, Klesse S, Köhler L, Gabdoulline R, Kloos A, Liebich A, Wichmann M, Chaturvedi A, Fabisch J, Gaidzik V I, Paschka P, Bullinger L, Bug G, Serve H, Göhring G, Schlegelberger B, Lübbert M, Kirchner H, Wattad M, Kraemer D, Hertenstein B, Heil G, Fiedler W, Krauter J, Schlenk R F, Döhner K, Döhner H, Ganser A, Heuser |
| Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features. Oncotarget 2016 Jul . Palomo Laura, Garcia Olga, Arnan Montse, Xicoy Blanca, Fuster Francisco, Cabezón Marta, Coll Rosa, Ademà Vera, Grau Javier, Jiménez Maria-José, Pomares Helena, Marcé Sílvia, Mallo Mar, Millá Fuensanta, Alonso Esther, Sureda Anna, Gallardo David, Feliu Evarist, Ribera Josep-Maria, Solé Francesc, Zamora Lurd |
| EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia. Journal of cancer research and clinical oncology 2016 May . Schäfer Vivien, Ernst Jana, Rinke Jenny, Winkelmann Nils, Beck James F, Hochhaus Andreas, Gruhn Bernd, Ernst Thom |
| RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia 2016 May . Gaidzik V I, Teleanu V, Papaemmanuil E, Weber D, Paschka P, Hahn J, Wallrabenstein T, Kolbinger B, Köhne C-H, Horst H A, Brossart P, Held G, Kündgen A, Ringhoffer M, Götze K, Rummel M, Gerstung M, Campbell P, Kraus J M, Kestler H A, Thol F, Heuser M, Schlegelberger B, Ganser A, Bullinger L, Schlenk R F, Döhner K, Döhner |
| Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 May . Wang Sa A, Tam Wayne, Tsai Albert G, Arber Daniel A, Hasserjian Robert P, Geyer Julia T, George Tracy I, Czuchlewski David R, Foucar Kathryn, Rogers Heesun J, Hsi Eric D, Bryan Rea B, Bagg Adam, Dal Cin Paola, Zhao Chong, Kelley Todd W, Verstovsek Srdan, Bueso-Ramos Carlos, Orazi Attil |
| Recurrent CDKN1B (p27) mutations in hairy cell leukemia. Blood 2015 Aug 126 (8): 1005-8. Dietrich Sascha, Hüllein Jennifer, Lee Stanley Chun-Wei, Hutter Barbara, Gonzalez David, Jayne Sandrine, Dyer Martin J S, Ole? Ma?gorzata, Else Monica, Liu Xiyang, S?abicki Miko?aj, Wu Bian, Troussard Xavier, Dürig Jan, Andrulis Mindaugas, Dearden Claire, von Kalle Christof, Granzow Martin, Jauch Anna, Fröhling Stefan, Huber Wolfgang, Meggendorfer Manja, Haferlach Torsten, Ho Anthony D, Richter Daniela, Brors Benedikt, Glimm Hanno, Matutes Estella, Abdel Wahab Omar, Zenz Thorst |
| Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
| Mutational spectrum of adult T-ALL. Oncotarget 2015 Feb 6 (5): 2754-66. Neumann Martin, Vosberg Sebastian, Schlee Cornelia, Heesch Sandra, Schwartz Stefan, Gökbuget Nicola, Hoelzer Dieter, Graf Alexander, Krebs Stefan, Bartram Isabelle, Blum Helmut, Brüggemann Monika, Hecht Jochen, Bohlander Stefan K, Greif Philipp A, Baldus Claudia |
| CALR mutation screening in pediatric primary myelofibrosis. Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
| The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. Leukemia 2014 Sep 28 (9): 1804-10. Guglielmelli P, Lasho T L, Rotunno G, Score J, Mannarelli C, Pancrazzi A, Biamonte F, Pardanani A, Zoi K, Reiter A, Duncombe A, Fanelli T, Pietra D, Rumi E, Finke C, Gangat N, Ketterling R P, Knudson R A, Hanson C A, Bosi A, Pereira A, Manfredini R, Cervantes F, Barosi G, Cazzola M, Cross N C P, Vannucchi A M, Tefferi |
| TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations. International journal of hematology 2014 Jul 100 (1): 96-104. Tian Xiaopeng, Xu Yang, Yin Jia, Tian Hong, Chen Suning, Wu Depei, Sun Aini |
| Gene mutation patterns in patients with minimally differentiated acute myeloid leukemia. Neoplasia (New York, N.Y.) 2014 Jun 16 (6): 481-8. Kao Hsiao-Wen, Liang Der-Cherng, Wu Jin-Hou, Kuo Ming-Chung, Wang Po-Nan, Yang Chao-Ping, Shih Yu-Shu, Lin Tung-Huei, Huang Yu-Hui, Shih Lee-Yu |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
| Mutations and prognosis in primary myelofibrosis. Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
| Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
| EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia. PloS one 2013 8 (4): e61341. Wang Xiuli, Dai Haiping, Wang Qian, Wang Qinrong, Xu Yang, Wang Ying, Sun Aining, Ruan Jia, Chen Suning, Wu Dep |
- Page last reviewed:Jul 25, 2022
- Page last updated:Nov 22, 2022
- Content source: